Operon Discontinues Sale of Arrays in N. America Due to Concerns about Affy Patents

Jun 01, 2001

NEW YORK, June 1 - Qiagen subsidiary Operon said it has discontinued sales of its pre-fabricated, medium-density OpArrays in North America, due to concerns that they might infringe on Affymetrix’s patent portfolio.

Operon attorneys have interpreted Affymetrix’s patents as covering any array with over 60 unique features per square centimeter, while they previously interpreted Affymetrix’s patents as covering any array with over 400 features per square centimeter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu